cancer
At 19, Eldiara Doucette faced rare sarcoma and arm amputation, but turned her grief into empowerment and resilience.
Adding short-term ADT to high-dose radiotherapy improved disease-free survival for patients with prostate cancer.
Pembrolizumab effectively shrank or eliminated tumors for 90% of patients with unresectable advanced desmoplastic melanoma
To determine prognosis for patients with melanoma, clinicians can access the free tool online at www.brainmetgpa.com.
Adding human papillomavirus (HPV) testing to urine cytology may improve the detection of bladder cancer.
A poster at the 2025 ASCO Annual Meeting identified gaps in clinical trial enrollment in the community oncology setting.
Reduced elective dose in head and neck cancer radiotherapy was safe but didn’t improve diet scores versus standard dose.
Research suggests that the use of immune checkpoint inhibitors may double psoriasis risk for patients with cancer.
Nearly one-third of patients with pancreatic cancer missed germline testing, with disparities tied to race and insurance.
President Carter’s Legacy and the Future of Immunotherapy
Adding “cancer” to the atrial fibrillation calculation model improved the predictability of assessing the probability of ...
Measuring the impact of diet and lifestyle habits on patient outcomes to determine if these factors can enhance the accuracy ...
“With the increasing population of cancer survivors, there is an urgent need to identify feasible strategies to help ...
180 Mount Airy Road Suite 205
Basking Ridge, NJ 07920
Connect
The content of this site is intended for healthcare professionals.
© 2025 Physician’s Weekly, a Formedics PropertyAny views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Physician’s Weekly, their employees, and affiliates.